Resumen de SEOM clinical guidelines in early stage breast cancer (2018)

Francisco Ayala de la Peña, Raquel Andrés Conejero, José Ángel García Sáenz, Luis Manso Sánchez, Mireia Margelí Vila, Elsa Dalmau Pórtulas, S. Pernas, Aleix Prat, Sònia Servitja Tormo, Eva Ciruelos

• Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20–30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.